Autopsy report · NCT03726112

Spoton Trial Evaluating the Efficacy on BAlance Disorder sYmptoms (STEADY)

“Under internal considerations”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 110 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

SpotOn Therapeutics Ltd.

Sponsor type

Industry

Conditions

Balance Disorders

Interventions

SpotOn Specs; Sham Specs

Participants

110 (planned, not actual)

Sites

1

Countries

Israel

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.